Seizert Capital Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1M | Buy |
125,541
+3,571
| +3% | +$1.03M | 1.59% | 32 |
|
|
2025
Q1 | $37.6M | Buy |
121,970
+81,752
| +203% | +$25.2M | 1.72% | 31 |
|
|
2024
Q4 | $14.2M | Buy |
40,218
+1,312
| +3% | +$463K | 0.64% | 41 |
|
|
2024
Q3 | $13.9M | Buy |
38,906
+14,465
| +59% | +$5.18M | 0.63% | 45 |
|
|
2024
Q2 | $7.79M | Sell |
24,441
-834
| -3% | -$266K | 0.39% | 57 |
|
|
2024
Q1 | $5.81M | Buy |
25,275
+201
| +0.8% | +$46.2K | 0.27% | 66 |
|
|
2023
Q4 | $5.51M | Sell |
25,074
-4,084
| -14% | -$898K | 0.28% | 65 |
|
|
2023
Q3 | $6.59M | Buy |
29,158
+3,777
| +15% | +$853K | 0.35% | 55 |
|
|
2023
Q2 | $5.6M | Sell |
25,381
-315
| -1% | -$69.5K | 0.3% | 65 |
|
|
2023
Q1 | $5.75M | Sell |
25,696
-1,395
| -5% | -$312K | 0.32% | 65 |
|
|
2022
Q4 | $7.53M | Sell |
27,091
-7,114
| -21% | -$1.98M | 0.4% | 58 |
|
|
2022
Q3 | $7.16M | Sell |
34,205
-463
| -1% | -$96.9K | 0.4% | 57 |
|
|
2022
Q2 | $8.17M | Sell |
34,668
-8,238
| -19% | -$1.94M | 0.43% | 56 |
|
|
2022
Q1 | $7.7M | Sell |
42,906
-560
| -1% | -$100K | 0.35% | 62 |
|
|
2021
Q4 | $9.39M | Sell |
43,466
-6,643
| -13% | -$1.44M | 0.42% | 56 |
|
|
2021
Q3 | $9.25M | Buy |
50,109
+2,026
| +4% | +$374K | 0.42% | 58 |
|
|
2021
Q2 | $8.63M | Sell |
48,083
-28,857
| -38% | -$5.18M | 0.41% | 59 |
|
|
2021
Q1 | $12.9M | Sell |
76,940
-261
| -0.3% | -$43.7K | 0.67% | 49 |
|
|
2020
Q4 | $11.7M | Sell |
77,201
-6,602
| -8% | -$1M | 0.68% | 49 |
|
|
2020
Q3 | $8.46M | Buy |
83,803
+10,197
| +14% | +$1.03M | 0.56% | 49 |
|
|
2020
Q2 | $8.91M | Sell |
73,606
-8,471
| -10% | -$1.02M | 0.6% | 45 |
|
|
2020
Q1 | $7.78M | Buy |
+82,077
| New | +$7.78M | 0.57% | 48 |
|
|
2014
Q1 | – | Sell |
-652,383
| Closed | -$73.8M | – | 218 |
|
|
2013
Q4 | $73.8M | Buy |
652,383
+37,502
| +6% | +$4.24M | 1.75% | 15 |
|
|
2013
Q3 | $48.5M | Sell |
614,881
-42,781
| -7% | -$3.37M | 1.32% | 34 |
|
|
2013
Q2 | $43.3M | Buy |
+657,662
| New | +$43.3M | 1.18% | 39 |
|